drugset / Trial / NCT01570478

A Study in Patients With Asthma

NCT01570478

Phase 3 Completed 108 enrolled Chiesi Farmaceutici S.p.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the present study is to demonstrate the higher efficacy of Foster® NEXThaler® 100/6 extra fine (two inhalations b.i.d.) versus Seretide® Accuhaler® 250/50 (one inhalation b.i.d.), in terms of pulmonary function (change from baseline to the end of treatment in post-dose peripheral airway resistance) in patients with asthma.

Timeline

Start
2012-07
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Beclomethasone Small molecule 400 ug Inhaled
Comparator Fluticasone Other / unclassified 500 ug Inhaled
Subject Formoterol Other / unclassified 24 ug Inhaled
Comparator Salmeterol Other / unclassified 100 ug Inhaled

Indications